RKLB AI Stock Analysis – Buy, Hold, or Avoid?
Rocket Lab USA, Inc. (RKLB)
Fundamentals
Rocket Lab USA, Inc. (RKLB) remains in a stage of significant investment and operating losses as it scales its aerospace offerings. The company is reporting accelerating revenues with improving operational efficiencies, yet it continues to operate at a substantial net loss, reflecting an investment-heavy phase typical for space and aerospace defense firms focused on long-term growth.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
63.46% YoY
Q1 2026
Net Income
25.73% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 200.3M | 179.7M | 155.1M | 144.5M | 122.6M | 132.4M | 104.8M | 106.3M |
| Revenue Growth YoY | +63.46% | +35.70% | +47.97% | +36.00% | +32.13% | +120.68% | +54.90% | +71.25% |
| Net Income | -45.0M | -52.9M | -18.3M | -66.4M | -60.6M | -52.3M | -51.9M | -41.6M |
| Net Income Growth YoY | +25.73% | -1.10% | +64.85% | -59.53% | -36.95% | -3.66% | -28.03% | +9.28% |
| EPS | -$0.07 | -$0.09 | -$0.03 | -$0.13 | -$0.12 | -$0.10 | -$0.10 | -$0.08 |
| EPS Growth YoY | +41.67% | +7.60% | +65.50% | -54.39% | -32.89% | 0.00% | -19.33% | +12.02% |
Profitability Metrics
Technical Analysis
Rocket Lab USA (RKLB) is currently in a consolidation phase with price well below major moving averages, signaling a bearish primary trend. However, the presence of a golden cross and a strong ADX reading suggests underlying strength, while RSI remains neutral indicating no extreme momentum. Traders should watch for a breakout above resistance levels to confirm trend reversal.
No extreme reading
Price in downtrend
Strong trend active
Watching for cross
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Rocket Lab USA, Inc. (RKLB) remains in a stage of significant investment and operating losses as it scales its aerospace offerings. The company is reporting accelerating revenues with improving operational efficiencies, yet it continues to operate at a substantial net loss, reflecting an investment-heavy phase typical for space and aerospace defense firms focused on long-term growth.
Latest Earnings
Q1 2026 Earnings (Mar 31, 2026)
Earnings Per Share (EPS)
Actual
$-0.02
Estimated
$-0.07
Surprise
+$0.05
Surprise %
+70.18%
Revenue
Actual
$200.35M
Estimated
$189.65M
Surprise
+$10.7M
Surprise %
+5.64%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $-0.02 | $-0.09 | $0.01 | $-0.10 | $-0.12 | $-0.10 | $-0.10 | $-0.08 |
| EPS (Estimated) | $-0.07 | $-0.10 | $-0.10 | $-0.10 | $-0.11 | $-0.09 | $-0.09 | $-0.10 |
| EPS Surprise | +$0.05 | +$0.01 | +$0.11 | -$0.00 | -$0.01 | -$0.01 | -$0.01 | +$0.02 |
| % Diff | +70.2% | +8.9% | +110.1% | -5.0% | -12.6% | -11.1% | -6.7% | +20.0% |
| Revenue | ||||||||
| Revenue (Actual) | $200.35M | $179.65M | $155.08M | $144.5M | $122.57M | $132.39M | $104.81M | $106.25M |
| Revenue (Estimated) | $189.65M | $176.83M | $151.8M | $135.41M | $121.4M | $130.57M | $102.28M | $105.46M |
| Revenue Surprise | +$10.7M | +$2.83M | +$3.28M | +$9.08M | +$1.17M | +$1.82M | +$2.53M | +$791K |
| % Diff | +5.6% | +1.6% | +2.2% | +6.7% | +1.0% | +1.4% | +2.5% | +0.8% |
Valuation
Rocket Lab USA (RKLB) presents a complex valuation profile characterized by rapid revenue growth and substantial profitability challenges. Despite significant negative earnings and operating losses, the stock commands lofty valuation multiples driven by strong contract backlog and growth outlook. Analyst sentiment remains generally bullish with price targets implying notable upside potential from current levels.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | -229.36 | -188.74 | -347.17 | -68.79 | -37.25 | -63.67 | -24.32 | -13.48 |
| Price to Sales | 194.07 | 222.31 | 163.34 | 127.51 | 73.76 | 96.53 | 46.20 | 21.12 |
| Price to Book | 17.17 | 23.20 | 19.77 | 26.76 | 20.96 | 33.41 | 11.53 | 4.93 |
| Enterprise Value to EBITDA | -1231.73 | -1799.01 | -530.98 | -350.71 | -184.04 | -318.43 | -118.28 | -70.81 |
| Enterprise Value to Revenue | 188.74 | 219.11 | 161.47 | 127.05 | 75.28 | 98.02 | 47.90 | 22.37 |
Sentiment & Analyst Ratings
Rocket Lab (RKLB) sentiment is broadly positive, supported by strong analyst ratings favoring Buy and Strong Buy, bolstered by recent multi-launch contracts and progress on the Neutron rocket development. While news highlights solid growth drivers and strategic acquisitions, investor sentiment is tempered by concerns about profitability, cash burn, and integration risks.
Analyst Recommendations
Risk Assessment
Rocket Lab demonstrates a solid liquidity position with strong current and quick ratios, reflecting ample short-term asset coverage and low leverage on its balance sheet. However, its continued negative earnings, challenges in Neutron rocket development, and reliance on government contracts pose execution and market risks. While its financial health is favorable compared to many peers, elevated valuation and competitive pressures weigh on the risk profile.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q1 2026
Quick Ratio
Latest Quarter: Q1 2026
Debt-to-Equity
Latest Quarter: Q1 2026
Debt-to-Assets
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 4.47 | 4.08 | 3.18 | 2.67 | 2.08 | 2.04 | 2.58 | 2.82 |
| Quick Ratio | 4.02 | 3.61 | 2.83 | 2.33 | 1.72 | 1.69 | 2.16 | 2.43 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 0.06 | 0.15 | 0.40 | 0.72 | 1.14 | 1.22 | 1.12 | 1.04 |
| Debt-to-Assets | 0.05 | 0.11 | 0.23 | 0.32 | 0.39 | 0.40 | 0.41 | 0.40 |
Liquidity Assessment
Current Ratio: 4.47(Strong)
Quick Ratio: 4.02(Strong)
The company has strong liquidity with sufficient short-term assets to cover liabilities.
Solvency Assessment
Debt-to-Equity: 0.06(Low)
Debt-to-Assets: 0.05(Low)
The company has conservative debt levels, indicating low financial risk and strong long-term solvency.
Frequently Asked Questions about RKLB
AI Answers: Common Questions About RKLB
Get AI-powered answers to the questions investors ask most about Rocket Lab USA, Inc.
RKLB is a good long-term buy due to strong revenue growth (146% from 2023 to 2025) and improving margins (gross margin near 38%), but near-term investors should be cautious given ongoing losses and technical consolidation.
Selling is not recommended unless there is a failure in key projects like the Neutron rocket or loss of major contracts, as fundamentals and backlog support growth despite current unprofitability.
Main risks include Neutron rocket development delays, reliance on government contracts, strong competition, and continued capital-intensive operations leading to losses.
Upside technical targets include $78 (200 SMA), $85 (150 SMA), and $97 (50 SMA) on confirmed breakouts; downside support is near the 52-week low at $37.57.
RKLB trades at a deeply negative P/E (-324.75) and very high price-to-sales multiples, reflecting growth expectations and backlog strength rather than current profitability.
Fundamentals show accelerating revenue ($601M in 2025), improving gross margins (up to 38%), and narrowing EPS losses (-$0.02 in Q1 2026), but the company remains unprofitable with heavy R&D spending.
Technicals indicate a bearish primary trend with price below major SMAs, but a golden cross and strong ADX suggest potential for reversal pending breakout above $78 resistance.
Key catalysts include the Neutron rocket launch success, new government and commercial launch contracts, and quarterly earnings reports showing margin and revenue improvements.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.